These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1091391)

  • 41. Liver scan in hyperlipoproteinemia.
    Sachs BA; Bardfeld PA; Bodian JE; Sugarman LA; Hellman L
    JAMA; 1974 Feb; 227(8):907-10. PubMed ID: 4590252
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma 25-hydroxy-vitamin D in familial hypercholesterolemic children receiving colestipol resin.
    Tsang RC; Roginsky MS; Mellies MJ; Glueck CJ
    Pediatr Res; 1978 Oct; 12(10):980-2. PubMed ID: 724301
    [No Abstract]   [Full Text] [Related]  

  • 43. Bile acid sequestrants and cholesterol.
    Schon P
    N Z Med J; 1990 Apr; 103(887):163. PubMed ID: 2111529
    [No Abstract]   [Full Text] [Related]  

  • 44. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
    Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
    Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of hypercholesterolemia. Can it retard atherogenesis?
    Untereker WJ
    Int J Cardiol; 1982; 2(1):57-9. PubMed ID: 7129690
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypocholesterolemic activity of colestipol hydrochloride in SEA quail.
    Day CE
    Artery; 1989; 17(1):49-59. PubMed ID: 2589993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
    Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
    Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
    [No Abstract]   [Full Text] [Related]  

  • 50. New microporous cholestyramine analog for treatment of hypercholesterolemia.
    De Simone R; Conti F; Lovati MR; Sirtori M; Cocuzza E; Sirtori CR
    J Pharm Sci; 1978 Dec; 67(12):1695-8. PubMed ID: 722483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia.
    Davis TA; Anderson EC; Ginsburg AV; Goldberg AP
    J Lab Clin Med; 1985 Oct; 106(4):447-54. PubMed ID: 4045301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE; Illingworth DR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
    Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
    [No Abstract]   [Full Text] [Related]  

  • 54. Hypocholesterolemic effect of ascorbic acid in maturity-onset diabetes mellitus.
    Ginter E; Zdichynec B; Holzerová O; Tichá E; Kobza R; Koziaková M; Cerná O; Ozdín L; Hrubá F; Nováková V; Sasko E; Gaher M
    Int J Vitam Nutr Res; 1978; 48(4):368-73. PubMed ID: 367979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colestipol hydrochloride prophylaxis of diarrhea during pelvic radiotherapy.
    Stryker JA; Chung CK; Layser JD
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):185-90. PubMed ID: 6833021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colesevelam hydrochloride.
    Steinmetz KL
    Am J Health Syst Pharm; 2002 May; 59(10):932-9. PubMed ID: 12040732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colesevelam hydrochloride: a novel bile acid-binding resin.
    Aldridge MA; Ito MK
    Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM
    Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
    Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
    N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.